Inventor · disambiguated record
Byron Hua Kwan
Also filed as: KWAN BYRON HUA
5 granted patents·1 pending application·64 citations·filing 2013–2021
79Inventor score
Top patents by PatentIndex Score
6 records- 0194US9844582B2Synergistic tumor treatment with extended-PK IL-2 and therapeutic agentsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Dec 19, 2017·38 cites·41 claims
- 0293US10166273B2Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion proteinMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Jan 1, 2019·19 cites·20 claims
- 0387US11096989B2Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion proteinUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Aug 24, 2021·3 cites·31 claims
- 0485US10888603B2Methods of treating cancer cells expressing tumor-associated integrinsMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Jan 12, 2021·4 cites·35 claims
- 0568US2022193197A1Synergistic tumor treatment with il-2 and integrin-binding-fc fusion proteinUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 0651US12421312B2Anti-PD-L1 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2020·Granted Sep 23, 2025·0 cites·51 claims
Join the waitlist — get patent alerts
Get an alert when Byron Hua Kwan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →